Virtu Financial LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$82,000
+3.8%
16,138
-5.6%
0.01%
+100.0%
Q1 2019$79,000
-75.8%
17,101
-67.2%
0.00%
-80.0%
Q3 2018$327,000
-9.4%
52,182
+7.9%
0.02%
+5.3%
Q1 2018$361,000–48,342–0.02%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q4 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders